封面
市場調查報告書
商品編碼
1313387

神經血管設備市場:按類型、用途- 2023-2030 年全球預測

Neurovascular Neurology Devices Market by Type, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2023 年,全球神經血管設備市場將達到 30.0527 億美元,年複合成長率7.77%,預計到 2030 年將出現驚人成長,達到 50.8234 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球神經血管器械市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標,我們對供應商進行全面評估,使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限,並取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻,可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解:

1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2. 市場開發:提供有關利潤豐厚的新興市場的詳細資訊,並分析其在成熟市場的滲透率。

3. 市場多元化:提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢:全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題:

1.神經血管器械全球市場規模及預測是多少?

2.在預測期內,COVID-19 對全球神經血管器械市場的阻礙因素和影響有哪些?

3. 在預測期內,全球神經血管設備市場需要投資哪些產品/細分市場/用途/領域?

4.你們在全球神經血管器材市場的競爭策略是什麼?

5. 全球神經血管器械市場的技術趨勢和法律規範是什麼?

6.全球神經血管器械市場主要廠商的市佔率是多少?

7. 哪些型態和策略性措施被認為適合進入全球神經血管器械市場?

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 神經病變的發生率增加
      • 高血壓、飲酒和吸煙增加
      • 微創手術需求不斷成長
    • 抑制因素
      • 缺乏熟練的神經外科醫生
    • 機會
      • 神經血管設備相關技術進步快速成長
      • 採用先進的血栓清除技術
    • 任務
      • 神經血管手術的手術費用高
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 神經血管設備市場:依類型

  • 介紹
  • 頸動脈支架系統
  • 腦動脈瘤及AVM血管內栓塞系統
  • 腦血栓清除器
  • 動脈瘤分流器
  • 顱內支架系統

第7章 神經血管設備市場:依用途

  • 介紹
  • 腦動脈瘤
  • 腦動脈狹窄
  • 中風

第8章 美洲神經血管設備市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太神經血管器材市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲神經血管器材市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析:主要企業
  • 競爭情境分析:主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-036C5CF3B4E5

The Global Neurovascular Neurology Devices Market is forecasted to grow significantly, with a projected USD 3,005.27 million in 2023 at a CAGR of 7.77% and expected to reach a staggering USD 5,082.34 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Neurovascular Neurology Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Neurovascular Neurology Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Carotid Artery Stenting System, Cerebral Aneurysm & AVM Endovascular Embolization Systems, Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, and Intracranial Stent Systems. The Cerebral Thrombectomy Devices is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cerebral Aneurysm, Cerebral Artery Stenosis, and Stroke. The Cerebral Aneurysm is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Neurovascular Neurology Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neurovascular Neurology Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurovascular Neurology Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurovascular Neurology Devices Market?

4. What is the competitive strategic window for opportunities in the Global Neurovascular Neurology Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Neurovascular Neurology Devices Market?

6. What is the market share of the leading vendors in the Global Neurovascular Neurology Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Neurovascular Neurology Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neurovascular Neurology Devices Market, by Type, 2022 vs 2030
  • 4.3. Neurovascular Neurology Devices Market, by Application, 2022 vs 2030
  • 4.4. Neurovascular Neurology Devices Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the incidence of neurological disorders
      • 5.1.1.2. Increasing prevalence of hypertension, alcohol consumption, and smoking
      • 5.1.1.3. Rising demand for minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled neurosurgeons
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in technological advancements related to neurovascular devices
      • 5.1.3.2. Adoption of advances in thrombectomy technologies
    • 5.1.4. Challenges
      • 5.1.4.1. High procedural cost of neurovascular surgeries
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Neurovascular Neurology Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Carotid Artery Stenting System
  • 6.3. Cerebral Aneurysm & AVM Endovascular Embolization Systems
  • 6.4. Cerebral Thrombectomy Devices
  • 6.5. Flow Diverter for Aneurysm
  • 6.6. Intracranial Stent Systems

7. Neurovascular Neurology Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cerebral Aneurysm
  • 7.3. Cerebral Artery Stenosis
  • 7.4. Stroke

8. Americas Neurovascular Neurology Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neurovascular Neurology Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neurovascular Neurology Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. NEUROVASCULAR NEUROLOGY DEVICES MARKET DYNAMICS
  • FIGURE 8. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM & AVM ENDOVASCULAR EMBOLIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTER FOR ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INTRACRANIAL STENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 101. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 102. NEUROVASCULAR NEUROLOGY DEVICES MARKET LICENSE & PRICING